Nr507 Week 7 Disease Process Presentation
Purpose
The purpose of the Nr507 Week 7 Disease Process Presentation is for learners to:
- Develop professional presentation/communication skills.
- Demonstrate an advancing understanding of pathophysiological processes of body systems that result in the diagnosis and treatment of patients who present with these disorders in these systems.
- Demonstrate the ability to analyze the literature to obtain the most current, evidence-based resources on the assigned disease process.
- Demonstrate and practice professional communication and leadership, while advancing the education of peers.
Due Date: Tuesday 11:59 PM MT Week 7 to both the Week
7 discussion board and the Week 7 assignment area.
Course outcomes
- Analyze pathophysiological mechanisms associated with select disease states.
- Relate research findings to the management of patients with complex pathophysiologic dysfunction.
Total Points Possible: 200 points
Requirements
Description of the Assignment
For Week 7 of the course, there is no case study given to you by the faculty. Instead you will be creating an audio/video recorded presentation that demonstrates your understanding of a selected disease process. This presentation will be uploaded into the course via Kaltura (see course resources for directions).
Criteria for Content
- Introduce the disease with a brief definition and description.
- Discuss the Risk Factorsand the connection to the Etiology of the initial injury to the cell/tissue/organ.
- Discuss health care provider implications for prevention of the disease.
- Show the progression from the initial injury to the defect in the tissue, organ and system functioning.
- Link changes in the tissue, organ, and system functioning to the initial presenting signs and symptoms seen in primary careof the disease.
- Provide a brief description of how the disease is diagnosed.
- Provide a brief description of the pharmacological and non-pharmacological interventions used to treat and manage the disease.
- Summarizes the disease on final slide with concluding remarks; includes implication for nurse practitioner practice.
- Utilizes at least two current (within 5 years), peer-reviewed scholarly sources to support presentation content.
- Reference slide and in-text citations depict references correctly cited according to APA.
Nr507 Week 7 Disease Process Answer
Diabetes Mellitus Type 1 (DM1), formerly known as insulin-dependent diabetes or juvenile diabetes, is a chronic condition characterized by the pancreas producing insufficient or no insulin due to autoimmune destruction of beta cells (ADA, 2018). As defined by Katsarou et al. (2017), insulin is a crucial hormone facilitating the entry of glucose into cells for energy production. While more prevalent in children and adolescents, DM1 can also manifest in adults.
The intricate interplay of glucose metabolism involves the breakdown of carbohydrates into glucose by the digestive system. This glucose is then transported through the bloodstream to cells. The pancreas plays a pivotal role in this process by secreting insulin, enabling the movement of glucose from the blood into the body’s cells (Zaccardi, Webb, Yates, & Davies, 2016). Within the cells, glucose undergoes combustion with oxygen to generate energy.
However, in individuals with type 1 diabetes, the pancreas fails to produce adequate insulin to regulate blood glucose levels (Katsarou et al., 2017). This imbalance results in elevated blood glucose levels and diminished glucose availability within cells for energy production, culminating in the manifestation of diabetes type 1 (Zaccardi et al., 2016).
Understanding the intricate mechanisms and disruptions in glucose metabolism in DM1 is crucial for healthcare practitioners to provide effective care and management for individuals with this condition. This knowledge empowers healthcare professionals to devise tailored interventions, ensuring optimal outcomes and improved quality of life for patients with diabetes type 1.
References: American Diabetes Association (ADA). (2018). Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes—2018. Diabetes Care, 41(Supplement 1), S13–S27.
Katsarou, A., Gudbjörnsdottir, S., Rawshani, A., Dabelea, D., Bonifacio, E., Anderson, B. J., Jacobsen, L. M., Schatz, D. A., Lernmark, Å., & Type 1 Diabetes Mellitus Nat. Hist. Consort. (2017). Type 1 diabetes mellitus. Nature Reviews Disease Primers, 3, 17016. https://doi.org/10.1038/nrdp.2017.16
Zaccardi, F., Webb, D. R., Yates, T., & Davies, M. J. (2016). Pathophysiology of type 1 and type 2 diabetes mellitus: A 90-year perspective. Postgraduate Medical Journal, 92(1084), 63–69. https://doi.org/10.1136/postgradmedj-2015-133281
